Ftse Mib
35.373,89
-0,10%
DAX
18.686,78
-0,21%
S&P 500
5.297,10
0,00%
NASDAQ
16.698,32
0,00%
Bitcoin
66.263,52
1,57%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni Australia ASX CSL Limited (CSL) CSL Limited (CSL) Notizie

CSL

CSL (CSL)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:ASX:CSL
DataOraFonteTitoloSimboloCompagnia
02/05/202318:44Dow Jones NewsTravere Therapeutics Shares Touch 52-Week Low on FSGS Study DataASX:CSLCSL Limited
02/11/202216:34Dow Jones NewsArcturus Therapeutics Shares Rise 31% After Vaccine CollaborationASX:CSLCSL Limited
02/11/202200:27Dow Jones NewsArcturus Up 26% After Hours on CSL Seqirus Vaccine CollaborationASX:CSLCSL Limited
14/12/202109:54Dow Jones NewsVifor Pharma Surges Again as Board Recommends CSL Bid Valuing Equity at $11.7 BillionASX:CSLCSL Limited
14/12/202108:00Dow Jones NewsCSL Makes US$11.7 Billion Offer for Switzerland's Vifor Pharma -- 2nd UpdateASX:CSLCSL Limited
14/12/202107:49Dow Jones NewsCSL Makes US$11.7 Billion Offer for Switzerland's Vifor Pharma -- UpdateASX:CSLCSL Limited
14/12/202107:24Dow Jones NewsCSL Makes US$11.7 Billion Offer for Switzerland's Vifor PharmaASX:CSLCSL Limited
13/12/202101:49Dow Jones NewsCSL in Talks With Vifor Pharma Over Potential TransactionASX:CSLCSL Limited
11/12/202001:57Dow Jones NewsCovid-19 Vaccine Candidate Scrapped After False Positives on HIV TestsASX:CSLCSL Limited
07/09/202001:06Dow Jones NewsCSL Signs 2 Initial Agreements for Coronavirus Vaccine SupplyASX:CSLCSL Limited
19/08/202011:46Dow Jones NewsCoronavirus Pandemic Slashes Donations of Lifesaving PlasmaASX:CSLCSL Limited
09/12/201915:12Dow Jones NewsCSL Bering Gets FDA Orphan Designation for HizentraASX:CSLCSL Limited
14/05/201915:20Dow Jones NewsHaemonetics Cuts Guidance on CSL Plasma DealASX:CSLCSL Limited
23/10/201814:58Dow Jones NewsSeqirus Gets FDA Approval for Afluria Quadrivalent in Young ChildrenASX:CSLCSL Limited
01/12/201612:05NewspaperShould you buy Australian Foundation Investment Co Ltd?ASX:CSLCSL Limited
27/07/201609:32Dow Jones NewsAustralia Stocks Close Near Flat After Mixed Inflation DataASX:CSLCSL Limited
26/07/201609:14Dow Jones NewsAustralia Stocks End up Slightly as Key Inflation Data LoomsASX:CSLCSL Limited
16/10/201501:37Dow Jones NewsCSL Catches Cold from Flu Vaccines Deal with Novartis -- Market TalkASX:CSLCSL Limited
17/08/201504:19Dow Jones NewsIs A$100 a Share Cursed? -- Market TalkASX:CSLCSL Limited
04/08/201510:18Dow Jones NewsAustralian Shares End Higher, Helped by Earnings and Sales DataASX:CSLCSL Limited
28/07/201510:28Dow Jones NewsAustralia Shares End Slightly Down; Energy Stocks RiseASX:CSLCSL Limited
23/04/201501:20Dow Jones NewsCSL Says CFO Naylor to Lead Influenza-Vaccine BusinessASX:CSLCSL Limited
17/03/201504:01The Motley FoolWhat do rising U.S. interest rates mean for Australian companies? ASX:CSLCSL Limited
11/02/201506:54Dow Jones NewsCSL Shaves Guidance as Competition Heats Up-- UpdateASX:CSLCSL Limited
03/12/201413:18Dow Jones NewsDrooping Commodities Hurt Down Under -- Barron's AsiaASX:CSLCSL Limited
27/10/201403:31Dow Jones NewsCSL to Buy Novartis Influenza-Vaccine UnitASX:CSLCSL Limited
26/10/201423:49Dow Jones NewsCSL to Buy Novartis Influenza-Vaccine Unit for $275 MillionASX:CSLCSL Limited
24/01/201408:22Dow Jones NewsAustralia Shares End Lower on China Growth Concerns, DataASX:CSLCSL Limited
13/01/201413:20Dow Jones NewsU.S. Stock Futures Are LowerASX:CSLCSL Limited
13/01/201401:44Dow Jones NewsS&P/ASX 200 Down 0.2% in Quiet TradeASX:CSLCSL Limited
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:ASX:CSL

La tua Cronologia

USOTC
PPRRF
TrueContext (PK)
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network